Skip to main content
Name of Target:
Similar to PBTZ-169. MIC reported as 0.15 ug/ml. Active in vivo, orally bioavailable, 12.5 mg/kg
2020.Guo S et al. In vitro and in vivo antimicrobial activities of a novel piperazine-containing benzothiazinones candidate TZY-5-84 against M. tuberculosis. Biomed Pharmacother. 131:110777.
©2016 Working Group on New TB Drugs. All Rights Reserved.
Terms of Reference
Site by Darby Communications